<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>Bioresearch Online News</title>
    <description>News Articles</description>
    <link>http://www.bioresearchonline.com/</link>
    <pubDate>Fri, 10 Feb 2012 19:55:43 GMT</pubDate>
    <item>
      <title>FDA Issues Draft Guidance On Biosimilar Product Development</title>
      <description> The U.S. Food and Drug Administration today issued three draft guidance documents on biosimilar product development to assist industry in developing such products in the United States. </description>
      <link>http://www.bioresearchonline.com/article.mvc/FDA-Issues-Draft-Guidance-On-Biosimilar-Produ-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Fri, 10 Feb 2012 19:55:43 GMT</pubDate>
    </item>
    <item>
      <title>INTERPHEX Unveils Conference Programming For May 2012 Event</title>
      <description>The organizers and Advisory Board of INTERPHEX have reengineered the 2012 conference program, to be held at New York's Javits Center on May 1-3, 2012.</description>
      <link>http://www.bioresearchonline.com/article.mvc/INTERPHEX-Unveils-Conference-Programming-For-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Thu, 09 Feb 2012 08:53:00 GMT</pubDate>
    </item>
    <item>
      <title>Courtagen To Partner With Tetracore In Biodefense Initiative</title>
      <description>Courtagen Life Sciences, Inc. ("Courtagen"), a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry, recently announced that it has entered into a strategic collaboration with Tetracore, Inc. ("Tetracore") to develop a next generation biothreat assay for identifying and diagnosing high priority biological agents in clinical and environmental samples.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Courtagen-To-Partner-With-Tetracore-In-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Thu, 09 Feb 2012 08:29:00 GMT</pubDate>
    </item>
    <item>
      <title>Integrated DNA Technologies Acquires 1st BASE Oligonucleotide Business In Singapore</title>
      <description>Integrated DNA Technologies (IDT) has acquired the oligonucleotide business of Singapore's top supplier in the field, 1st BASE Pte. Ltd (1st BASE).</description>
      <link>http://www.bioresearchonline.com/article.mvc/Integrated-DNA-Technologies-Acquires-1st-BASE-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Thu, 09 Feb 2012 05:26:00 GMT</pubDate>
    </item>
    <item>
      <title>Roche's xCELLigence Cardio Instrument Used To Detect Beating Rhythm And Proarrhythmic Effects Of Compounds In Stem Cell-Derived Cardiomyocytes</title>
      <description>In an effort to improve preclinical cardiotoxicity assays, reduce drug testing attrition rates, and ensure drug safety, collaborating scientists at the University Medical Center Utrecht in the Netherlands, and Bioscience Department of AstraZeneca R&amp;D, Mölndal, Sweden, have tested Roche's xCELLigence Cardio Instrument.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Roches-xCELLigence-Cardio-Instrument-Used-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Thu, 09 Feb 2012 05:07:00 GMT</pubDate>
    </item>
    <item>
      <title>Safe Evaporation Of Diethyl Ether Assists Lipid Extractions</title>
      <description>The Inert Gas Purge (IGP) system, available for use with most Genevac evaporators, enables safe operation even when working with highly explosive solvents, those with a low flash point, very low auto-ignition temperature and a wide explosive vapour saturation range.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Safe-Evaporation-Of-Diethyl-Ether-Assists-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Wed, 08 Feb 2012 08:26:00 GMT</pubDate>
    </item>
    <item>
      <title>Cytomedix Expands Commitment To Regenerative Medicine With Acquisition Of Aldagen</title>
      <description>Cytomedix, Inc. (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announces the completion of the acquisition of Aldagen, Inc., a privately held biopharmaceutical company developing regenerative cell therapies based on its proprietary ALDH bright cell ("ALDHbr") technology.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Cytomedix-Expands-Commitment-To-Regenerative-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Wed, 08 Feb 2012 07:44:00 GMT</pubDate>
    </item>
    <item>
      <title>TSI Announces New Remote Particle Counters With 4-20 mA Analog Outputs</title>
      <description>TSI Incorporated is pleased to announce a new range of Remote Particle Counters with 4-20 mA Analog Outputs.</description>
      <link>http://www.bioresearchonline.com/article.mvc/TSI-Announces-New-Remote-Particle-Counters-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Wed, 08 Feb 2012 04:49:00 GMT</pubDate>
    </item>
    <item>
      <title>Dow AgroSciences, BioDuro To Collaborate On Crop Protection Discovery Research</title>
      <description>Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company, and BioDuro, a PPD Company, announced recently a three-year, multi-program discovery research agreement to generate novel molecules for synthesizing and testing fungicides, insecticides, and herbicides across a variety of crops. </description>
      <link>http://www.bioresearchonline.com/article.mvc/Dow-AgroSciences-BioDuro-To-Collaborate-On-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Tue, 07 Feb 2012 13:00:00 GMT</pubDate>
    </item>
    <item>
      <title>China Emerging As An Innovation Hub For Formulation And Delivery</title>
      <description>A clutch of promising Chinese companies in the formulation and delivery (F/D) market underlines the emergence of the Asian giant as a center for biopharma innovation and entrepreneurship, even as Western pharmaceutical companies continue to enjoy technological and business advantages, according to a Lux Research report titled, "The Expanding Formulation and Delivery Market in China." </description>
      <link>http://www.bioresearchonline.com/article.mvc/China-Emerging-As-An-Innovation-Hub-For-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Tue, 07 Feb 2012 12:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Marken Enhances Presence In China</title>
      <description>Marken announced recently that it has recently received approval for its application for an expanded business license to allow the storage and distribution of clinical trial supplies and drug product in China.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Marken-Enhances-Presence-In-China-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Tue, 07 Feb 2012 08:19:00 GMT</pubDate>
    </item>
    <item>
      <title>Good Timing: NIST/CU Collaboration Adds Timing Capability To Living Cell Sensors</title>
      <description>Individual cells modified to act as sensors using fluorescence are already useful tools in biochemistry, but now they can add good timing to their resumé, thanks in part to expertise from the National Institute of Standards and Technology (NIST).</description>
      <link>http://www.bioresearchonline.com/article.mvc/Good-Timing-NISTCU-Collaboration-Adds-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Tue, 07 Feb 2012 08:08:00 GMT</pubDate>
    </item>
    <item>
      <title>Brooks Life Science Systems And The Scripps Research Institute Initiate Partnership</title>
      <description>Brooks Life Science Systems, a division of Brooks Automation, Inc., a leading worldwide provider of automation solutions for compound and biological sample storage and management, recently announced the initiation of a technology development and commercialization partnership with The Scripps Research Institute (Scripps Research).</description>
      <link>http://www.bioresearchonline.com/article.mvc/Brooks-Life-Science-Systems-And-The-Scripps-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Tue, 07 Feb 2012 08:00:00 GMT</pubDate>
    </item>
    <item>
      <title>NIST Announces Program To ID Human Cell Lines For Research</title>
      <description>The National Institute of Standards and Technology (NIST) has announced that it is launching a project to collect and catalog DNA identification data for up to 1,500 human cell lines used in biological and medical research.</description>
      <link>http://www.bioresearchonline.com/article.mvc/NIST-Announces-Program-To-ID-Human-Cell-Lines-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Tue, 07 Feb 2012 07:57:00 GMT</pubDate>
    </item>
    <item>
      <title>Siemens Forms New Companion Diagnostics Partnerships With ViiV Healthcare And Tocagen</title>
      <description>Siemens Healthcare Diagnostics announces two new companion diagnostics partnerships with pharmaceutical companies ViiV Healthcare and Tocagen - marking a major step for Siemens (NYSE: SI) into this important and fast-growing segment of the in vitro diagnostics (IVD) market.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Siemens-Forms-New-Companion-Diagnostics-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Tue, 07 Feb 2012 06:13:00 GMT</pubDate>
    </item>
    <item>
      <title>Treatment For TB Can Be Guided By Patients' Genetics</title>
      <description>A gene that influences the inflammatory response to infection may also predict the effectiveness of drug treatment for a deadly form of tuberculosis. &lt;i&gt;By Leila Gray &lt;/i&gt;</description>
      <link>http://www.bioresearchonline.com/article.mvc/Treatment-For-TB-Can-Be-Guided-By-Patients-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Tue, 07 Feb 2012 05:39:00 GMT</pubDate>
    </item>
    <item>
      <title>Drug Delivery Hits It Big In Vegas</title>
      <description>Pharma and biotech experts from around the globe gathered in Las Vegas from January 25 to 27 for Drug Delivery Partnerships 2012 (DDP). Vegas seemed an appropriate location, because drug development is a high stakes game filled with risk and reward. </description>
      <link>http://www.bioresearchonline.com/article.mvc/Drug-Delivery-Hits-It-Big-In-Vegas-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Mon, 06 Feb 2012 21:14:00 GMT</pubDate>
    </item>
    <item>
      <title>Why Bad Immunity Genes Survive</title>
      <description>University of Utah biologists found new evidence why mice, people and other vertebrate animals carry thousands of varieties of genes to make immune-system proteins named MHCs - even though some of those genes make us susceptible to infections and to autoimmune diseases.</description>
      <link>http://www.bioresearchonline.com/article.mvc/Why-Bad-Immunity-Genes-Survive-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Mon, 06 Feb 2012 07:57:00 GMT</pubDate>
    </item>
    <item>
      <title>LifeLines Biobank Buys New BiOS System From Hamilton Storage Technologies</title>
      <description>Hamilton Storage Technologies announced recently the sale of one of the first -80°C BiOS third-generation automated storage systems to the LifeLines Study at the University Medical Center Groningen (UMCG), The Netherlands.</description>
      <link>http://www.bioresearchonline.com/article.mvc/LifeLines-Biobank-Buys-New-BiOS-System-From-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Mon, 06 Feb 2012 07:21:00 GMT</pubDate>
    </item>
    <item>
      <title>'Smarter Particle Sizing' On Malvern Booth At Pittcon 2012  Booth #3641</title>
      <description>Materials characterization company Malvern Instruments focuses on 'smarter particle sizing' as the Mastersizer 3000 laser diffraction particle size analyzer makes its Pittcon debut in 2012 (Booth #3641 Pittcon 2012, 11-15 Mar 2012, Orlando, FL).</description>
      <link>http://www.bioresearchonline.com/article.mvc/Smarter-Particle-Sizing-On-Malvern-Booth-At-0001?atc~c=771+s=773+r=001+l=a</link>
      <pubDate>Mon, 06 Feb 2012 07:02:00 GMT</pubDate>
    </item>
  </channel>
</rss>
